Log in
02.11.2023

Deal |

2023

Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients

  • HQ: CH

Founded: 2012

  • Series C
  • Sector: Biotechnology

Investment Raised: CHF 25M €

Valuation Remains Undisclosed

Investors: Adjuvant Capital (https://adjuvantcapital.com/) Fresenius Medical Care (https://www.freseniusmedicalcare.com/en/home) GF Group Holding (https://gfgroup.ch/de/) Pureos Bioventures (https://www.pureosbio.com/) Redalpine (https://redalpine.com/) Schroders (https://www.schroders.com/de-at/at/local/) Swisscanto Private Equity (https://www.swisscanto.com/ch/en.html) Verve Ventures (https://www.verve.vc/) Vesalius Biocapital Partners (https://vesaliusbiocapital.com/)

News Link
17.10.2023

Deal |

2023

The Netherlands: Tessellate BIO emerges from stealth

  • HQ: NL

Founded: 2020

  • Seed
  • Sector: Biotechnology

Investment Raised: EUR 8M €

Valuation Remains Undisclosed

Investors: BioGeneration Ventures (https://biogenerationventures.com/en/) Forbion Capital Partners (https://forbion.com/en)

News Link
12.10.2023

Deal |

2023

Bon Vivant toasts taking $15.9M to brew up versatile animal-free dairy proteins

  • HQ: FR

Founded: 2021

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: USD 15.9M €

Valuation Remains Undisclosed

Investors: CapTech (https://www.captechconsulting.com/) Sofinnova Partners (https://sofinnovapartners.com/) Sparkfood (https://sparkfood.com/)

News Link
11.10.2023

Deal |

2023

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

  • HQ: BE

Founded: 2017

  • Series C
  • Sector: Biotechnology

Investment Raised: USD 100M €

Valuation Remains Undisclosed

Investors: AdBio partners (https://adbio.partners/) Andera Partners (https://www.anderapartners.com/en/) Canaan Partners (https://www.canaan.com/) Cormorant Asset Management Dawn Biopharma (https://dawnpharma.com/) EQT life science (https://eqtgroup.com/private-capital/life-sciences/) Fidelity Management and Research Company (https://www.fidelity.com/about-fidelity/our-company) Pfizer (https://www.pfizer.de/) Pontifax (https://www.pontifax.com/) Redmile Group (https://redmilegroup.com/) Walleye Capital (https://www.walleyecapital.com/)

News Link
09.10.2023

Deal of the Week |

Calendar Week # 41 |

2023

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

  • HQ: BE

Founded: 2017

  • Series C
  • Sector: Biotechnology

Investment Raised: USD 100M €

Valuation Remains Undisclosed

Investors: AdBio partners (https://adbio.partners/) Andera Partners (https://www.anderapartners.com/en/) Canaan Partners (https://www.canaan.com/) Cormorant Asset Management Dawn Biopharma (https://dawnpharma.com/) EQT life science (https://eqtgroup.com/private-capital/life-sciences/) Fidelity Management and Research Company (https://www.fidelity.com/about-fidelity/our-company) Pfizer (https://www.pfizer.de/) Pontifax (https://www.pontifax.com/) Redmile Group (https://redmilegroup.com/) Walleye Capital (https://www.walleyecapital.com/)

News Link
08.10.2023

Deal |

2023

LimmaTech Biologics Raises $37M in Series A Funding

  • HQ: CH

Founded: 2015

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 37M €

Valuation Remains Undisclosed

Investors: Adjuvant Capital (https://adjuvantcapital.com/) AXA Investment Managers (https://www.axa-im.de/) Novo Holdings (https://novoholdings.dk/) Repair Impact Fund (https://www.repair-impact-fund.com/)

News Link
04.10.2023

Deal |

2023

Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio

  • HQ: IE

Founded: 2018

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 35M €

Valuation Remains Undisclosed

Investors: Enterprise Ireland (https://www.enterprise-ireland.com/en/) Kurma Partners (https://www.kurmapartners.com/en) Seroba Life Sciences (https://seroba-lifesciences.com/)

News Link
03.10.2023

Deal |

2023

Scaling Automata secures another £33m

  • HQ: UK

Founded: 2015

  • Venture Round
  • Sector: Biotechnology

Investment Raised: GBP 33M €

Valuation Remains Undisclosed

Investors: A.P. Moller Holding (https://apmoller.com/) aldeA Ventures (https://aldea.ventures/) Dimension (https://dimensionpartners.vc/) Hummingbird Ventures (https://www.hummingbird.vc/) Isomer Capital (https://isomercapital.com/) Octopus Ventures (https://octopusventures.com/) Possible Ventures (https://www.possible.ventures/)

News Link
02.10.2023

Deal |

2023

Mogrify extends Series A financing to $46 million USD

  • HQ: UK

Founded: 2016

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 46M €

Valuation Remains Undisclosed

Investors: Ahren Innovation Capital (https://www.ahreninnovationcapital.com/) Astellas Venture Management (https://www.astellasventure.com/) Jonathan Milner Parkwalk Advisors (https://parkwalkadvisors.com/)

News Link
28.09.2023

Deal |

2023

Laverock raises £13.5m to develop unique gene silencing platform

  • HQ: LT

Founded: 2018

  • Seed Round
  • Sector: Biotechnology

Investment Raised: GBP 13.5M €

Valuation Remains Undisclosed

Investors: Calculus Capital (https://calculuscapital.com/) Eli Lilly (https://www.lilly.com/) Eos (https://www.eosventurepartners.com/) Maven Capital Partners (https://www.mavencp.com/) Mercia Fund Managers (https://www.mercia.co.uk/) Tekfen Ventures (https://www.tekfenventures.com/) UK Innovation & Science Seed Fund (https://ukinnovationscienceseedfund.co.uk/)

News Link
28.09.2023

Deal |

2023

Nagi Bioscience secures 12.4M CHF investment with an oversubscribed Series A funding round

  • HQ: DE

Founded: 2019

  • Series A
  • Sector: Biotechnology

Investment Raised: CHF 12.4M €

Valuation Remains Undisclosed

Investors: Excellis (https://www.excellishealth.com/) imec.xpand (https://imecxpand.com/) Swisscanto Private Equity (https://www.swisscanto.com/ch/de.html) Verve Ventures (https://www.verve.vc/) Zürcher Kantonal Bank (https://www.zkb.ch/)

News Link
26.09.2023

Deal |

2023

Acesion wins €45m in Series B funding to develop atrial fibrillation therapy

  • HQ: DK

Founded: 2011

  • Series B
  • Sector: Biotechnology

Investment Raised: EUR 45M €

Valuation Remains Undisclosed

Investors: Alpha Wave Global (https://www.alphawaveglobal.com/) Canaan Partners (https://www.canaan.com/) Global BioAccess Fund Novo Holdings (https://novoholdings.dk/)

News Link
25.09.2023

Deal |

2023

traceless materials Raises €36.6M in Series A Funding

  • HQ: UK

Founded: 2020

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 36.6M €

Valuation Remains Undisclosed

Investors: b.value AG (https://bvalue.de/) Blue Oceans Partners (https://www.blueocean-partner.de/) GLS Community Bank eG Hamburger Sparkasse AG High-Tech Grunderfonds (https://www.htgf.de/de/) Planet A Ventures United Bankers (https://unitedbankers.fi/)

News Link
20.09.2023

Deal |

2023

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

  • HQ: CH

Founded: 2017

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 39m €

Valuation Remains Undisclosed

Investors: BioMedPartners (https://biomedvc.com/en/) Pierre Fabre Invest (https://www.pierre-fabre.com/)

News Link
19.09.2023

Deal |

2023

AbolerIS Pharma Announces €27 Million in Series A Financing led by Caixa Capital Risc to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases

  • HQ: FR

Founded: 2019

  • Series A
  • Sector: Biotechnology

Investment Raised: EUR 27.3m €

Valuation Remains Undisclosed

Investors: Caixa Capital Risc (https://www.caixacapitalrisc.es/) Investsud (https://investsud.be/) Newton Biocapital (https://newtonbiocapital.com/) Sambrinvest (https://www.sambrinvest.be/fr/) SFPIM (https://sfpim.be/en/) Sound Bioventures (https://soundbioventures.com/) Turenne Groupe (https://www.turennecapital.com/) Wallonie Entreprendre (https://www.wallonie-entreprendre.be/fr/)

News Link
13.09.2023

Deal |

2023

Mironid Extends Series A Funding; £35M Raised To Date

  • HQ: UK

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: GBP 35M €

Valuation Remains Undisclosed

Investors: 83North (https://www.83north.com/) Dell Technologies Capital (https://www.delltechnologies.com/en-us/capital.htm) Greenfield Partners Hazelnut Partners Qualcomm Ventures (https://www.qualcommventures.com/) Saban Ventures (http://www.saban.com/capital/)

News Link
13.09.2023

Deal |

2023

PRESSR: Rejuveron raises $75mln in dual tranche Series B and convertible loan financing

  • HQ: CF

Founded: 2018

  • Series B
  • Sector: Biotechnology

Investment Raised: USD 75M €

Valuation Remains Undisclosed

Investors: UBS (https://www.ubs.com/global/de.html)

News Link
11.09.2023

Deal |

2023

Biobest raises 400M EUR

  • HQ: BE

Founded: 1987

  • Venture – Series Unknown
  • Sector: Biotechnology

Investment Raised: EUR 400M €

Valuation Remains Undisclosed

Investors: bm-t beteiligungsmanagement thuringen (https://www.bm-t.de/en/) Marondo Capital (https://www.marondo.com/) TGFS – Technologiegründerfonds Sachsen (https://www.cfh.de/en/tgfs-start/)

News Link
07.09.2023

Deal |

2023

French biotech Corteria secures $70M to revive ex-Sanofi heart drugs

  • HQ: FR

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 70M €

Valuation Remains Undisclosed

Investors: Fountain Healthcare Partners (https://www.fh-partners.com/) Invivo Capital Partners Jeito Capital (https://jeito.life/) Kurma Partners (https://www.kurmapartners.com/) Omnes Capital (https://www.omnescapital.com/) OrbiMed V-Bio Ventures (https://v-bio.ventures/)

News Link
06.09.2023

Deal |

2023

Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital

  • HQ: UK

Founded: 2020

  • Series C
  • Sector: Biotechnology

Investment Raised: USD 226.5M €

Valuation Remains Undisclosed

Investors: M&G Plc (https://www.mandg.com/) Patient Square Capital (https://patientsquarecapital.com/) Rock Springs Capital (https://www.rockspringscapital.com/?source=post_page---------------------------)

News Link
12.07.2023

Deal |

2023

Tenpoint Therapeutics Raises $70M in Series A Financing

  • HQ: EN

Founded: 2021

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 70M €

Valuation Remains Undisclosed

Investors: British Patient Capital (https://www.britishpatientcapital.co.uk/) Eight Roads Ventures F-Prime Capital Qiming Venture Partners USA (https://www.qimingvcusa.com/) Sofinnova Partners (https://sofinnovapartners.com/) UCL Technology Fund (https://www.cbinsights.com/investor/ucl-technology-fund)

News Link
11.07.2023

Deal |

2023

Aphea.Bio Raises € 70M in Series C Funding

  • HQ: BEL

Founded: 2017

  • Series C
  • Sector: Biotechnology

Investment Raised: EUR 70M €

Valuation Remains Undisclosed

Investors: Agri Investment Fund (https://aifund.be/) Astanor Ventures (https://astanor.com/) Bill & Melinda Gates Foundation (https://www.gatesfoundation.org/) BNP Paribas Fortis (https://www.bnpparibasfortis.be/fr/public/particuliers) European Circular Bioeconomy Fund (https://www.ecbf.vc/) Innovation Industries (https://www.innovationindustries.com/) Korys (https://korys.be/en/) SFPIM (https://sfpim.be/en/)

News Link
26.06.2023

Deal |

2023

Actimed Therapeutics raises £5M to advance lead program for cancer cachexia

  • HQ: UK

Founded: 2020

  • Series A
  • Sector: Biotechnology

Investment Raised: GBP 5M €

Valuation Remains Undisclosed

Investors: Mankind Pharma (https://www.mankindpharma.com/)

News Link
20.06.2023

Deal |

2023

Adamo Foods Raises £1.5M for “Groundbreaking” Mycelium Steaks

  • HQ: UK

Founded: 2017

  • Pre-Seed
  • Sector: Biotechnology

Investment Raised: GBP 1M €

Valuation Remains Undisclosed

Investors: SFC Capital (https://www.sfccapital.com/)

News Link
20.06.2023

Deal |

2023

CHF12 million to ensure safe drinking water around the world bNovate

  • HQ: CH

Founded: 2018

  • Series C
  • Sector: Biotechnology

Investment Raised: CHF 12M €

Valuation Remains Undisclosed

Investors: Emerald Technology Ventures (https://emerald.vc/)

News Link
23.05.2023

Deal |

2023

smartbax Raises €1.2M in Seed Funding

  • HQ: DE

Founded: 2021

  • Seed
  • Sector: Biotechnology

Investment Raised: EUR 1M €

Valuation Remains Undisclosed

Investors: Boehringer Ingelheim Venture Fund (https://www.boehringer-ingelheim-venture.com/team.php) High-Tech Grunderfonds (https://www.htgf.de/de/)

News Link
17.05.2023

Deal |

2023

Cyted raises $16.8m funding to scale globally

  • HQ: UK

Founded: 2020

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 16.8M €

Valuation Remains Undisclosed

Investors: BGF (https://www.bgf.co.uk/) Morningside Ventures (https://morningside.com/)

News Link
11.05.2023

Deal |

2023

NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies

  • HQ: CH

Founded: 2022

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 50M €

Valuation Remains Undisclosed

Investors: Igor Fish Nicolas Mermod Recipharm Venture Fund (https://eqtgroup.com/current-portfolio/)

News Link
11.05.2023

Deal |

2023

Beefutures Raises $1.7 Million in Seed Round

  • HQ: NO

Founded: 2019

  • Seed
  • Sector: Biotechnology

Investment Raised: USD 1.7M €

Valuation Remains Undisclosed

Investors: Norselab (https://norselab.com/)

News Link
10.05.2023

Deal |

2023

French biotech DiogenX jumps into type 1 diabetes space with $30M Series A round

  • HQ: FR

Founded: 2019

  • Series A
  • Sector: Biotechnology

Investment Raised: USD 30M €

Valuation Remains Undisclosed

Investors: AdBio partners (https://adbio.partners/) Boehringer Ingelheim Venture Fund (https://www.boehringer-ingelheim-venture.com/team.php) Eli Lilly JDRF T1D Fund (https://t1dfund.org/) Roche Venture Fund (https://www.roche.com/venturefund/)

News Link